Lexaria Bioscience Corp. — Director's Dealing 2009

Jan 27, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRA)
CIK: 0001348362
Period of Report: 2009-01-26

Reporting Person: BUNKA CHRISTOPHER (Director, Chairman,CEO,President,CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-01-26	Common Shares	P	10000	$0.05	Acquired	2208050	Indirect
2009-01-27	Common Shares	P	20000	$0.05	Acquired	2228050	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	863600	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants	$0.6	2009-11-09	Common Shares (1166800)	1166800	Indirect
Stock Options	$0.8	2011-04-26	Common Shares (400000)	400000	Direct

Footnotes

F1: 863,600 shares are held directly by Chris Bunka. 1,364,450 shares and 1,166,800 warrants to purchase another 1,166,800 common shares, are held by Chris Bunka's wholly-owned private investment company, CAB Finacial Services Ltd.

F2: On June 19, 2007, the exercise price was reduced from $1.30.